Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health economics analysis of the ASTER trial from a European perspective.
Authors
Glover, Matthew J
Hughes, Victoria
Tournoy, Kurt G
Dooms, Christophe
Annema, Jouke T
Sharples, Linda D
Publication Date
2014-07Journal Title
Thorax
ISSN
0040-6376
Publisher
BMJ
Volume
69
Issue
7
Pages
679-681
Language
eng
Type
Article
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Rintoul, R., Glover, M. J., Jackson, C., Hughes, V., Tournoy, K. G., Dooms, C., Annema, J. T., & et al. (2014). Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health economics analysis of the ASTER trial from a European perspective.. Thorax, 69 (7), 679-681. https://doi.org/10.1136/thoraxjnl-2013-204374
Abstract
In the ASTER study, mediastinal staging was more accurate for patients randomised to combined endobronchial and endoscopic ultrasound, followed by surgical staging if endoscopy was negative, versus surgical staging alone. Here, we report survival, quality of life and cost effectiveness up to 6 months, for the UK, The Netherlands and Belgium, separately. Survival in the two arms of the study was similar. In all three countries, the endosonography strategy had slightly higher quality-adjusted life years over 6 months, and was cheaper. Therefore, based on clinical accuracy and cost effectiveness, we conclude that mediastinal staging should commence with endosonography.
Keywords
Humans, Lung Neoplasms, Lymphatic Metastasis, Postoperative Complications, Positron-Emission Tomography, Tomography, X-Ray Computed, Endosonography, Neoplasm Staging, Pneumonectomy, Survival Rate, Bayes Theorem, Sensitivity and Specificity, Prospective Studies, Quality of Life, Cost-Benefit Analysis, Belgium, Netherlands, Female, Male, United Kingdom
Identifiers
External DOI: https://doi.org/10.1136/thoraxjnl-2013-204374
This record's URL: https://www.repository.cam.ac.uk/handle/1810/280206
Rights
Licence:
http://www.rioxx.net/licenses/all-rights-reserved
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.